Serkan Sertel
Head And Neck Surgery
Heidelberg, BW, Germany
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Complementary Medicine in ENT: How Evidence-Based is Acupuncture?
Journal: Laryngo- rhino- otologie
Published: February 05, 2026
Association of the rs17822931 (538G > A, G180R) in the ABCC11 gene with risk of middle ear cholesteatoma in older adults: a hospital-based case-control study at Heidelberg University Hospital, Germany.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: August 07, 2025
Review and update on the use of the microanastomotic coupler device for arterial anastomosis in free tissue transfer.
Journal: The British journal of oral & maxillofacial surgery
Published: January 03, 2020
Comparison of acupuncture on specific and non-specific points for the treatment of painful temporomandibular disorders: A randomised controlled trial.
Journal: Journal of oral rehabilitation
Published: November 14, 2019
Acupuncture as Complementary Treatment for Acute Tinnitus: A Randomized Controlled Pilot Study.
Journal: Complementary medicine research
Published: May 09, 2019
Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2).
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 24, 2018
Are human ATP-binding cassette transporter C11 and earwax associated with the incidence of cholesteatoma?
Journal: Medical hypotheses
Published: October 11, 2017
L-Shaped Septal Extension Spreader Graft for Improvement of Tip Symmetry in Unilateral Cleft Lip Nose Deformities.
Journal: Annals of plastic surgery
Published: July 25, 2017
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2).
Journal: Breast cancer research and treatment
Published: April 03, 2017
Last Updated: 09/26/2026